Evidence map›Paper›PMID 37970011›Full record

ReviewACS omega2023

Recent Advancements in Extraction Techniques of Ashwagandha (

Sunil Shinde, Arun Kumar Balasubramaniam, Vallabh Mulay, Ganesh Saste, Aboli Girme, Lal Hingorani

Open access · goldAbstract readReview
In one paragraph

Review in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. International journal of molecular sciences · 2026
    Article
  7. Article
  8. Nutraceutical Applications ofFoods (Basel, Switzerland) · 2026
    Review
  9. Article
  10. Frontiers in nutrition · 2026
    Review
  11. Safety and Tolerability ofFood science & nutrition · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Extraction of Bioactive Compounds FromInternational journal of food science · 2025
    Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sunil ShindePharmanza Herbal Pvt. Ltd., Anand 388430, Gujarat, India.
Arun Kumar BalasubramaniamPharmanza Herbal Pvt. Ltd., Anand 388430, Gujarat, India.
Vallabh MulayPharmanza Herbal Pvt. Ltd., Anand 388430, Gujarat, India.
Ganesh SastePharmanza Herbal Pvt. Ltd., Anand 388430, Gujarat, India.
Aboli GirmePharmanza Herbal Pvt. Ltd., Anand 388430, Gujarat, India.ORCID https://orcid.org/0000-0002-1536-1656
Lal HingoraniPharmanza Herbal Pvt. Ltd., Anand 388430, Gujarat, India.
Directorate of Medicinal and Aromatic Plants Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ashwagandha, also known as

Identifiers

PMID37970011
PMCPMC10633886
OpenAlexW4387971776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.